Biden and Harris tout drug price cuts at joint rally
The Democrats announced a deal with pharmaceutical companies to cut Medicare prices for 10 top-selling drugs
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
What happened
President Joe Biden and Vice President Kamala Harris appeared together Thursday to celebrate Medicare's first successful price negotiation with drugmakers, as allowed under Biden's 2022 Inflation Reduction Act (IRA). Medicare will pay 38% to 79% below list price for 10 top-selling drugs when the newly negotiated prices take effect in 2026, saving taxpayers a projected $6 billion a year and Medicare beneficiaries $1.5 billion.
Who said what
The first joint appearance by Biden and Harris since the president dropped out of the race was "billed as an official White House policy event," but it "quickly took on the tone and feel of a campaign rally," The Washington Post said. "We finally beat Big Pharma," Biden told the crowd in Largo, Maryland, and "with not one Republican vote in the entire Congress." He called Harris, who provided the tie-breaking Senate vote for the IRA, an "incredible partner in the progress we've made," adding, "she's going to make one hell of a president."
Donald Trump, in a meandering press conference shortly afterward, called the IRA a "con job" and said he was "entitled to personal attacks" on Harris. "I don't have a lot of respect for her intelligence, and I think she'll be a terrible president," he said.
What next?
Medicare plans to negotiate lower prices on 15 more drugs in 2025 and 2026, and 20 drugs in the following years. It's not clear how much the price reductions will help individual beneficiaries, but the IRA's $2,000-a-year cap on personal drug spending and $35 monthly ceiling on insulin costs take effect for Medicare patients next year.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Peter has worked as a news and culture writer and editor at The Week since the site's launch in 2008. He covers politics, world affairs, religion and cultural currents. His journalism career began as a copy editor at a financial newswire and has included editorial positions at The New York Times Magazine, Facts on File, and Oregon State University.
-
How the FCC’s ‘equal time’ rule worksIn the Spotlight The law is at the heart of the Colbert-CBS conflict
-
What is the endgame in the DHS shutdown?Today’s Big Question Democrats want to rein in ICE’s immigration crackdown
-
‘Poor time management isn’t just an inconvenience’Instant Opinion Opinion, comment and editorials of the day
-
Trump links funding to name on Penn StationSpeed Read Trump “can restart the funding with a snap of his fingers,” a Schumer insider said
-
Trump reclassifies 50,000 federal jobs to ease firingsSpeed Read The rule strips longstanding job protections from federal workers
-
Supreme Court upholds California gerrymanderSpeed Read The emergency docket order had no dissents from the court
-
700 ICE agents exit Twin Cities amid legal chaosSpeed Read More than 2,000 agents remain in the region
-
Trump demands $1B from Harvard, deepening feudSpeed Read Trump has continually gone after the university during his second term
-
House ends brief shutdown, tees up ICE showdownSpeed Read Numerous Democrats joined most Republicans in voting yes
-
Trump’s Kennedy Center closure plan draws ireSpeed Read Trump said he will close the center for two years for ‘renovations’
-
Trump's ‘weaponization czar’ demoted at DOJSpeed Read Ed Martin lost his title as assistant attorney general
